US Stock MarketDetailed Quotes

AKTX Akari Therapeutics

Watchlist
  • 1.1850
  • -0.0050-0.42%
Close Apr 26 16:00 ET
9.39MMarket Cap-592P/E (TTM)

About Akari Therapeutics Company

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in Boston, MA.

Company Profile

SymbolAKTX
Company NameAkari Therapeutics
Listing DateJan 31, 2014
Founded2004
CEOMs. Rachelle S. Jacques
MarketNASDAQ
Employees12
Securities TypeDR
ADS Ratio1.0 : 2000.0
Fiscal Year Ends12-31
Address22 Boston Wharf Road,7th Floor
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02210
Phone1-929-274-7510
Websitehttp://www.akaritx.com

Company Executives

  • Name
  • Position
  • Salary
  • Rachelle S. Jacques
  • Director, President and Chief Executive Officer
  • 1.56M
  • Dr. John F. Neylan, M.D.
  • Chief Medical Officer
  • --
  • Dr. Miles Nunn
  • Chief Scientific Officer
  • --
  • Wendy F. DiCicco
  • Interim Chief Financial Officer
  • 277.66K
  • Melissa Bradford Klug
  • Chief Operating Officer
  • --
  • Raymond Prudo-Chlebosz, M.D.
  • Chairman of the Board
  • 113.00K
  • Mohamed Wael Ahmed Hashad
  • Independent Director
  • 35.18K
  • Dr. Samir R. Patel, M.D.
  • Independent Director
  • 9.81K
  • Michael Grissinger
  • Independent Director
  • 66.85K
  • Donald A. Williams
  • Independent Director
  • 71.78K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg